›Initial nonoperative management bundle
›Nil by mouth status
›Avoid oral intake until obstruction resolved
›IV fluids
›Balanced crystalloid bolus 10 to 20 mL/kg for hypovolemia
›Maintenance fluids adjusted to urine output and electrolytes
›Electrolyte correction
›Potassium replacement per institutional protocol
›Magnesium replacement per institutional protocol
›Nasogastric decompression
›Persistent vomiting
›Significant distension
›Respiratory compromise from gastric distension
Analgesia and antiemetics
›Symptom control medications
›Opioid analgesia options
›Fentanyl IV 25 to 50 micrograms
›Repeat every 5 to 10 minutes for severe pain
›Monitor respiratory rate and sedation
›Morphine IV 2 to 4 mg
›Repeat every 10 to 15 minutes as needed
›Avoid in severe hypotension
›Hydromorphone IV 0.2 to 0.5 mg
›Repeat every 10 to 15 minutes as needed
›Higher risk of oversedation in older adults
›Antiemetic options
›Ondansetron IV 4 mg
›Repeat once in 10 minutes for refractory nausea
›QT prolongation risk with repeated dosing
›Metoclopramide IV 10 mg
›Avoid if suspected mechanical complete obstruction with severe colic
›Extrapyramidal symptom risk
›Antimicrobial indications
›Suspected strangulation
›Fever and leukocytosis with CT ischemia signs
›Suspected perforation
›Free air on imaging
›Suspected aspiration pneumonia from vomiting
›Hypoxia with infiltrate
›Empiric regimens for intraabdominal source
›Piperacillin tazobactam IV 4.5 g every 6 hours
›Renal dosing adjustment when eGFR reduced
›Broad gram negative and anaerobe coverage
›Ceftriaxone IV 2 g daily
›Add metronidazole IV 500 mg every 8 hours
›Alternative when lower pseudomonas risk
›Meropenem IV 1 g every 8 hours
›Reserve for high risk resistant organisms
›Renal dosing adjustment when eGFR reduced
Procedural and operative pathway
›Surgical management elements
›Immediate operative pathway
›Closed loop obstruction
›Peritonitis
›Bowel ischemia signs on CT
›Perforation
›Nonoperative trial conditions
›Suspected adhesive obstruction
›No peritonitis
›No CT ischemia signs
›Clinical improvement within 24 to 48 hours
›Water soluble contrast challenge integration
›Use for partial adhesive obstruction guidance
›Failure markers prompting surgery
›No contrast progression to colon within 24 hours
›Persistent high nasogastric output
›Worsening pain or vitals
VTE prophylaxis and adjuncts
›Hospital course risk reduction
›Venous thromboembolism prophylaxis
›Enoxaparin subcutaneous 40 mg daily
›Renal dosing adjustment when eGFR < 30 mL/min
›Avoid if active bleeding
›Unfractionated heparin subcutaneous 5000 units every 8 to 12 hours
›Use when severe renal impairment
›Stress ulcer prophylaxis indications
›ICU admission
›Mechanical ventilation
›Coagulopathy